🇺🇸 Epinephrine 1:100,000 in United States

441 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 367 reports (83.22%)
  2. Dizziness — 11 reports (2.49%)
  3. Dyspnoea — 10 reports (2.27%)
  4. Pain — 10 reports (2.27%)
  5. Swelling Face — 8 reports (1.81%)
  6. Headache — 7 reports (1.59%)
  7. Injection Site Ulcer — 7 reports (1.59%)
  8. Palpitations — 7 reports (1.59%)
  9. Paraesthesia — 7 reports (1.59%)
  10. Vomiting — 7 reports (1.59%)

Source database →

Epinephrine 1:100,000 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Epinephrine 1:100,000 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Epinephrine 1:100,000 in United States?

Rio de Janeiro State University is the originator. The local marketing authorisation holder may differ — check the official source linked above.